BE762399A - Agent recalcifiant, procede de preparation et methode de recalcification - Google Patents
Agent recalcifiant, procede de preparation et methode de recalcificationInfo
- Publication number
- BE762399A BE762399A BE762399A BE762399A BE762399A BE 762399 A BE762399 A BE 762399A BE 762399 A BE762399 A BE 762399A BE 762399 A BE762399 A BE 762399A BE 762399 A BE762399 A BE 762399A
- Authority
- BE
- Belgium
- Prior art keywords
- recalcifying
- recalcification
- agent
- preparation process
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR707006583A FR2077918B1 (fr) | 1970-02-24 | 1970-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE762399A true BE762399A (fr) | 1971-08-02 |
Family
ID=9051186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE762399A BE762399A (fr) | 1970-02-24 | 1971-02-02 | Agent recalcifiant, procede de preparation et methode de recalcification |
Country Status (7)
Country | Link |
---|---|
US (1) | US3814812A (fr) |
BE (1) | BE762399A (fr) |
DE (1) | DE2105925C3 (fr) |
ES (1) | ES388527A1 (fr) |
FR (1) | FR2077918B1 (fr) |
GB (1) | GB1301973A (fr) |
NL (1) | NL7102255A (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5017613A (en) * | 1983-07-20 | 1991-05-21 | Sanofi, S. A. | Valproic acid preparations |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4301176A (en) * | 1980-08-18 | 1981-11-17 | Warner-Lambert Company | Method of administering calcium valproate |
FR2547499A1 (fr) * | 1983-06-15 | 1984-12-21 | Opochimiotherapie Lab | Medicaments contenant du dipropylacetate de calcium |
US4913906B1 (en) * | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
US5070710A (en) * | 1989-02-07 | 1991-12-10 | Sara Lee Corporation | Garment blank and method of making it |
WO2007025177A2 (fr) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenese par modulation du recepteur muscarinique |
EP2258358A3 (fr) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenèse avec un inhibiteur de l'acetylcholinestérase |
EP2377530A3 (fr) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation de neurogénèse par inhibition PDE |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (fr) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogénèse par modulation de l'angiotensine |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20080188457A1 (en) * | 2007-02-02 | 2008-08-07 | Braincells, Inc. | Modulation of Neurogenesis with Biguanides and GSK3-beta Agents |
WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2266992A (en) * | 1939-03-15 | 1941-12-23 | American Cyanamid Co | Therapeutic composition |
-
1970
- 1970-02-24 FR FR707006583A patent/FR2077918B1/fr not_active Expired
-
1971
- 1971-02-02 BE BE762399A patent/BE762399A/fr unknown
- 1971-02-09 DE DE2105925A patent/DE2105925C3/de not_active Expired
- 1971-02-19 NL NL7102255A patent/NL7102255A/xx unknown
- 1971-02-23 ES ES388527A patent/ES388527A1/es not_active Expired
- 1971-02-23 US US00117950A patent/US3814812A/en not_active Expired - Lifetime
- 1971-04-19 GB GB2241371A patent/GB1301973A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5017613A (en) * | 1983-07-20 | 1991-05-21 | Sanofi, S. A. | Valproic acid preparations |
Also Published As
Publication number | Publication date |
---|---|
DE2105925A1 (fr) | 1971-09-09 |
DE2105925B2 (de) | 1974-04-04 |
GB1301973A (fr) | 1973-01-04 |
US3814812A (en) | 1974-06-04 |
FR2077918A1 (fr) | 1971-11-05 |
NL7102255A (fr) | 1971-08-26 |
ES388527A1 (es) | 1974-04-16 |
FR2077918B1 (fr) | 1973-04-06 |
DE2105925C3 (de) | 1974-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE762438A (fr) | Procede de denicotinisation | |
BE799542A (fr) | Cholesterol-oxydase et son procede de preparation, | |
BE762399A (fr) | Agent recalcifiant, procede de preparation et methode de recalcification | |
CH550235A (fr) | Procede de preparation de nouvelles diphenylamines. | |
BE746548A (fr) | Nouvel oestratriol et procede de preparation | |
BE768119A (fr) | Procede de preparation de cycloalcanols et de cycloalcanones | |
BE765287A (fr) | Procede de preparation de derives de 3- | |
BE801604Q (fr) | Procede de preparation de la dl-methionine | |
BE767935A (fr) | Procede de forage dirige | |
BE777266A (fr) | Procede de micro-encapsulation | |
BE763011A (fr) | Procede de preparation de poly-organo-siloxanes | |
BE767990A (fr) | Procede de preparation de monochlorobenzaldehydes | |
BE774905A (fr) | Procede de preparation de metacroleine | |
BE762442A (fr) | Procede de noircissement | |
BE774498A (fr) | Procede de preparation de monofluoro-dichloromethane et de difluoro-monochloromethane | |
BE775519A (fr) | Procede de preparation de saligenol | |
BE764472A (fr) | Beta-rhodomycine v et son procede de preparation | |
BE801603Q (fr) | Procede de preparation de la dl-methionine | |
BE777062A (fr) | 3-sulfo-alkyl-6-hydroxy-pyridones-(2), leur procede de preparation et application | |
BE768303A (fr) | Procede de preparation de 1,1,2,2-tetrahydroperfluoro- alcanols | |
BE764926A (fr) | Procede de concentration | |
BE777447A (fr) | Procede de preparation de monothioalkylene-glycols | |
BE761797A (fr) | Procede de preparation de vinyl-trichlorosilane | |
BE768655A (fr) | Procede de preparation de zearalenone | |
BE788558A (fr) | Reglette de raccordement et son procede de |